Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy
Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy
Not yet recruiting · NCT07096986 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, glomerulonephritis, kidney disorder, nephritis, urinary system disorder | Not yet recruiting | Phase 2 | 2026-06-22 | NCT07096986 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire de Nice | 229 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU de Nice | Nice | France | 51 |